Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy
Amanda Winters, Grace Bosma, Diana Abbott, Mohd Minhajuddin, Craig T. Jordan, Daniel A. Pollyea, Jonathan A. Gutman
Topics & Concepts
MedicineVenetoclaxInternal medicineTransplantationCumulative incidenceMyeloid leukemiaOncologyHazard ratioHematopoietic stem cell transplantationAzacitidineUnivariate analysisLeukemiaMultivariate analysisChronic lymphocytic leukemiaConfidence intervalGeneChemistryBiochemistryGene expressionDNA methylationAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationChronic Myeloid Leukemia Treatments